Ceftazidime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg

Ceftazidime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg
Product Description

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftazidime + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.25) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for more information.

Read more Show less

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    International Approvals/Standards
  • Supplied from
    India
More specifications Fewer specifications

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile

More Products from BDR PHARMACEUTICALS INTERNATIONAL PVT. (99)

  • Cefoperazone sodium 1g / 500 mg / 250 mg + sulbactam sodium 1g / 500 mg / 250 mg inj

    Product Cefoperazone sodium 1g / 500 mg / 250 mg + sulbactam sodium 1g / 500 mg / 250 mg inj

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefoperazone sodium 1g / 500 mg / 250 mg + sulbactam sodium 1g / 500 mg / 250 mg inj. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for...
  • Cefoperazone sodium 1g / 500 mg / 250 mg + tazobactum sodium 125 mg / 62.5 mg /31.25 mg

    Product Cefoperazone sodium 1g / 500 mg / 250 mg + tazobactum sodium 125 mg / 62.5 mg /31.25 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefoperazone sodium 1g / 500 mg / 250 mg + tazobactum sodium 125 mg / 62.5 mg /31.25 mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us ...
  • Cefoperazone sodium 2 g / 1g + sulbactam sodium 1g / 500 mg inj

    Product Cefoperazone sodium 2 g / 1g + sulbactam sodium 1g / 500 mg inj

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefoperazone sodium 2 g / 1g + sulbactam sodium 1g / 500 mg inj. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for more information.
  • Cefpodoxime proxetil

    Product Cefpodoxime proxetil

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefpodoxime proxetil. It belongs to cephalosporins apis products category. Contact us for more information.
  • Cefprozil

    Product Cefprozil

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cefprozil. It belongs to cephalosporins apis products category. Contact us for more information.
  • Ceftazidime + sulbactam for injection (1000 + 500) / (500 + 250) mg

    Product Ceftazidime + sulbactam for injection (1000 + 500) / (500 + 250) mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftazidime + sulbactam for injection (1000 + 500) / (500 + 250) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Contact us for more information.
  • Ceftiofur sodium sterile & ceftiofur hcl

    Product Ceftiofur sodium sterile & ceftiofur hcl

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftiofur sodium sterile & ceftiofur hcl. It belongs to cephalosporins apis products category. Contact us for more information.
  • Ceftriaxone + sulbactam for injection (1000 + 500) / (500 + 250) / (250+125) / (125 + 62.5) mg

    Product Ceftriaxone + sulbactam for injection (1000 + 500) / (500 + 250) / (250+125) / (125 + 62.5) mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftriaxone + sulbactam for injection (1000 + 500) / (500 + 250) / (250+125) / (125 + 62.5) mg. It belobgs to antibacterial cephalosporins finish formulations products category. Cont...
  • Ceftriaxone sodium + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.5) / (125 + 15.62) mg

    Product Ceftriaxone sodium + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.5) / (125 + 15.62) mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes ceftriaxone sodium + tazobactum for injection (1000 + 125) / (500 + 62.5) / (250 + 31.5) / (125 + 15.62) mg. It belobgs to antibacterial cephalosporins finish formulations products c...
  • Certrorelix acetate injection (0.25 / vial)

    Product Certrorelix acetate injection (0.25 / vial)

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes certrorelix acetate injection (0.25 / vial). It belongs to gynaecology finish formulations products category. Contact us for more information.
  • Cetrizine di hcl

    Product Cetrizine di hcl

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cetrizine di hcl. It belongs toantiallergic apis category. Contact us for more information.
  • Cetrorelix acetate

    Product Cetrorelix acetate

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cetrorelix acetate. It belongs to infertility apis category. Contact us for more information.
show all 99 other products

BDR PHARMACEUTICALS INTERNATIONAL PVT. resources (1)